Clinical trial

Efficacy and Safety Study Comparing CPL409116 to Placebo in Participants With Active Rheumatoid Arthritis

NCT05374785

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-05-01

PhasePHASE2

Study timeline

Study start (actual)2022-05-01Date precision: day

Registry last updated2025-01-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

CPL409116DRUG

PlaceboOTHER

Sponsors & collaborators

Celon Pharma SAlead sponsor

National Center for Research and Development, Polandcollaborator

Mapped research locations

KyivUkraine2 WarsawPoland1 KrakowPoland1 PoznanPoland1 LodzPoland1 BydgoszczPoland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05374785 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.